Published in Am J Hum Genet on March 01, 1992
Nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy. J Med Genet (1997) 1.97
Approach to the diagnosis of congenital myopathies. Neuromuscul Disord (2013) 1.40
Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy. Hum Mol Genet (2011) 1.16
Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat (2010) 0.99
The sarcomeric protein nebulin: another multifunctional giant in charge of muscle strength optimization. Front Physiol (2012) 0.82
Distal myopathies. Neurol Clin (2014) 0.80
Nemaline myopathy: two autopsy reports. Childs Nerv Syst (1995) 0.77
Exclusion of two candidate loci for autosomal recessive nemaline myopathy. J Med Genet (1994) 0.75
Investigation of muscle disease. J Neurol Neurosurg Psychiatry (1996) 0.75
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet (1989) 62.23
Variable number of tandem repeat (VNTR) markers for human gene mapping. Science (1987) 25.71
Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies. Am J Hum Genet (1974) 23.66
An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics (1988) 6.51
A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet (1986) 4.65
Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. Proc Natl Acad Sci U S A (1989) 2.92
NEMALINE MYOPATHY. A NEW CONGENITAL MYOPATHY. Brain (1963) 2.50
The CEPH consortium linkage map of human chromosome 1. Genomics (1991) 2.09
Exclusion mapping. J Med Genet (1987) 1.48
Identification of a hypervariable microsatellite polymorphism within D9S15 tightly linked to Friedrich's ataxia. Hum Genet (1990) 1.14
Linkage analysis of myotonic dystrophy and sequences on chromosome 19 using a cloned complement 3 gene probe. J Med Genet (1983) 1.13
Dinucleotide repeat polymorphisms at the D11S419 and CD3D loci. Nucleic Acids Res (1990) 1.04
An exclusion map for facioscapulohumeral (Landouzy-Déjérine) disease. J Med Genet (1989) 1.04
Hereditary motor and sensory neuropathies. J Med Genet (1991) 1.02
Assignment of the gene for central core disease to chromosome 19. Hum Genet (1990) 1.00
Human antithrombin II (AT3) gene length polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res (1989) 0.85
Congenital nemaline myopathy. I. Defective organization of alpha-actinin is restricted to muscle. Muscle Nerve (1983) 0.84
Differentiation of Becker muscular dystrophy from limb-girdle muscular dystrophy and Kugelberg-Welander disease using a cDNA probe. Med J Aust (1990) 0.80
Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27
Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01
Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A (1977) 13.87
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75
Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature (1999) 7.73
The action of sulphites on the cystine disulphide linkages in wool: The influence of pH values on the reaction. Biochem J (1938) 7.61
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron (2000) 6.92
An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics (1988) 6.51
Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45
Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature (1986) 6.34
The Analysis of Proteins. III. Estimation of Histidine and Tyrosine by Bromination. Biochem J (1924) 5.91
The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature (1996) 5.69
Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet (1990) 5.16
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet (1998) 4.91
Regional localization on the human X of DNA segments cloned from flow sorted chromosomes. Nucleic Acids Res (1982) 4.67
The action of alkalis on wool: 1. The subdivision of the combined cystine into two fractions differing in their rate and mode of reaction with alkalis. Biochem J (1945) 4.64
Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature (1985) 4.62
Fragile X genotype characterized by an unstable region of DNA. Science (1991) 4.33
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature (1989) 4.08
Renal and neuronal abnormalities in mice lacking GDNF. Nature (1996) 4.06
Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet (2001) 3.83
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57
The action of sulphites on the cystine disulphide linkages of wool: 4. Methylation of the thiol groups of bisulphited wools. Biochem J (1944) 3.55
Immunoelectron microscopic localization of dystrophin in myofibres. Nature (1988) 3.37
The action of sulphites on the cystine disulphide linkages of wool: The subdivision of the combined cystine into four fractions differing in their reactivity towards sodium bisulphite. Biochem J (1942) 3.26
The methylation of wool with methyl sulphate and methyl halides. Biochem J (1941) 3.24
Incidence and origin of "null" alleles in the (AC)n microsatellite markers. Am J Hum Genet (1993) 3.18
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (1995) 3.15
Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet (1985) 3.08
Cardiovascular effects of implanted acrylic bone cement. Br Med J (1971) 3.05
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet (1991) 2.79
The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature (1988) 2.75
Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem (1990) 2.69
Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet (1987) 2.64
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet (1995) 2.57
PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet (1998) 2.52
The action of sulphites on the cysteine disulphide linkages in wool: The influence of temperature, time and concentration on the reaction. Biochem J (1941) 2.46
The structural and functional diversity of dystrophin. Nat Genet (1993) 2.43
Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature (1989) 2.43
A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci U S A (2001) 2.42
Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature (1997) 2.41
The action of formaldehyde on the cystine disulphide linkages in wool: The subdivision of the combined cystine into two fractions differing in their reactivity towards formaldehyde. Biochem J (1942) 2.40
Statistical errors in papers in the British Journal of Psychiatry. Br J Psychiatry (1979) 2.38
GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron (1998) 2.34
A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat Genet (1999) 2.27
Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci U S A (1999) 2.27
The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med (1997) 2.24
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22
Molecular profiles of inflammatory myopathies. Neurology (2002) 2.21
Rapid detection of CA polymorphisms in cloned DNA: application to the 5' region of the dystrophin gene. Am J Hum Genet (1991) 2.17
Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron (1989) 2.13
A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell (1986) 2.12
Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature (1991) 2.11
Inadvertent esophageal intubation in the field: reliance on a fool's "gold standard". Acad Emerg Med (1997) 2.07
Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet (1999) 2.04
Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci U S A (1991) 2.04
A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. Genomics (1988) 2.04
Human Y-chromosome-specific reiterated DNA. Science (1976) 2.02
Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet (2001) 2.01
Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology (2004) 1.98
Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet (2005) 1.96
Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers. Am J Hum Genet (1991) 1.95
Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11. J Biol Chem (1992) 1.91
The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus (2006) 1.91
Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89
Linkage studies with the gene for an X-linked syndrome of mental retardation, microcephaly and spastic diplegia (MRX2) Am J Med Genet (1988) 1.88
Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet (1995) 1.86
Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res (1988) 1.84
Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med (1991) 1.83
Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein. J Cell Biol (2000) 1.82
Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology (1989) 1.81
Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature (1988) 1.81
Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet (1988) 1.80
Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet (1999) 1.80
Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filaments. Trends Mol Med (2001) 1.76
Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci (1999) 1.74
Explanation for exclusive maternal origin for congenital form of myotonic dystrophy. Lancet (1993) 1.72
The action of alkalis on wool: 2. The identity of the lanthionine-forming and bisulphite-reactive fractions of the combined cystine of wool. Biochem J (1945) 1.71
Mapping the short arm of human chromosome 16. Genomics (1989) 1.69
Experiments on the methylation and acetylation of wool, silk fibroin, collagen and gelatin. Biochem J (1944) 1.68
Influence of anthropometric factors and joint laxity in the incidence of adolescent back pain. Spine (Phila Pa 1976) (1984) 1.68
Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science (1987) 1.66
Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol (1995) 1.65